CTRI/2017/10/010237
Completed
Phase 1
A phase 1 clinical trial for assessment of safety of a multi component botanical therapeutic SKB108.
SK Biolabs0 sites100 target enrollmentTBD
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- SK Biolabs
- Enrollment
- 100
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Adult healthy human volunteers
Exclusion Criteria
- •Patients suffering from any disease.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 1
A clinical trial to test the safety of a herbal drug.CTRI/2017/11/010352SK Biolabs100
Not yet recruiting
Phase 1
A preliminary study for testing a new drug to kidney stones treatmentnephrolithiasisN20.9C12.777.419.600RBR-6cf4xhHospital das Clínicas da Faculdade de Medicina de Ribeirão Preto
Terminated
Phase 1
A first-in-human study of VG161 in participants with advanced malignant tumours that have not responded to conventional therapies.Advanced malignant solid tumorsCancer - Other cancer typesCancer - Any cancerACTRN12620000244909Virogin Biotech Australia Pty. Ltd.7
Recruiting
Not Applicable
A Study to Evaluate Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of Tripegfilgrastim in Pediatric Solid Tumor/Lymphoma PatientsNeoplasmsKCT0002244Dong-A ST32
Completed
Phase 1
A Clinical Study to know the safety, pharmacokinetics and anticancer activity of NRC-2694-A in patients with advanced cancersCTRI/2014/01/004293ATCO Pharma Limited26